Posted by Michael Wonder on 13 Aug 2018
Fewer Australians are dying from hepatitis C, but thousands are still missing out on treatment
13 August 2018 - The number of Australians dying from liver failure and liver cancer related to hepatitis C has dropped by 20% in just two years, according to preliminary data released today by The Kirby Institute.
It follows the introduction of highly effective, low-cost curative drugs to the PBS in 2016.
"This decline reflects the high uptake of direct-acting antiviral therapies among people with hepatitis C, particularly those with more advanced liver disease," said Greg Dore from the Kirby Institute.
